Betsy Tanner
Nurse Practitioner · Waycross, GANPI 1295387751
Payments from drug & device makers
Across 66 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$211
- Johnson & Johnson$194
- Amgen$93
- Teva Pharmaceuticals USA, Inc.$89
- AstraZeneca$87
- Radius Health, Inc.$70
- plus $635 from 18 others
What the payments were for
- Food & beverage$1,27993%
- Education$1007%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 10 | $211 |
| Johnson & Johnson | 5 | $194 |
| Amgen | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| AstraZeneca | 5 | $87 |
| Radius Health, Inc. | 3 | $70 |
| Sanofi | 2 | $69 |
| Mallinckrodt Hospital Products Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lilly USA, LLC | 4 | $62 |
| AbbVie | 4 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Pfizer | 2 | $39 |
| Organon | 1 | $27 |
| Abbott | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Insmed, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Aspira Women's Health Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
How this compares
$1,378 in reported general payments places this provider in the 75th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 60 | $66,597 |
| OzempicSemaglutide | 42 | $55,499 |
| TrulicityDulaglutide | 27 | $33,379 |
| JardianceEmpagliflozin | 21 | $24,850 |
| LinzessLinaclotide | 21 | $19,301 |
| EliquisApixaban | 17 | $18,101 |
| JanuviaSitagliptin Phosphate | 17 | $16,742 |
| FarxigaDapagliflozin Propanediol | 16 | $16,103 |
| EntrestoSacubitril/Valsartan | 13 | $12,680 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $6,098 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,141 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $3,041 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $2,342 |
| Azelastine Hcl | 60 | $1,965 |
| SynthroidLevothyroxine Sodium | 13 | $1,247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $62 | $99,97687 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $19 | $30,94835 claims |
| AbbVieLinzess, Synthroid | $53 | $20,54734 claims |
| PfizerEliquis | $39 | $18,10117 claims |
| AstraZenecaFarxiga | $87 | $16,10316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Waycross
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.